Invest right. Invest now. #KhataKholaKya

Reliance snaps 8-day losing streak

Blog | F&O

Good morning!☕🗞️

Check out the open interest of the companies from the F&O corner that are making headlines  ⤵️

Options setup (Expiry: 23 March)

Nifty50 Max Call OI 17,800
Nifty50 Max Put OI 17,000
Max Pain 17,100
PCR 0.89
Bank Nifty Max Call OI 41,500
Bank Nifty Max Put OI 39,500
Max Pain 39,600
PCR 1.04

⭐Reliance snaps 8-day losing streak
₹2,269 68 (+3.1%)

Reliance Industries shares rose over 3% on Tuesday after falling for eight straight sessions. This comes after the central government slashed the windfall tax on domestic crude oil to ₹3,500 from ₹4,400 per tonne. The OI of its March Futures contract declined 5.4%, indicating short-covering. Meanwhile, the call option OI on the 2,280 and 2,300 contracts fell 15% and 27%, respectively.

⭐NTPC subsidiary signs MoU with Indian Army
₹176 0.9 (+0.5%)

NTPC Renewable Energy, a subsidiary of India's largest energy conglomerate, signed an MoU with the Indian Army to set up green hydrogen projects at Army establishments. Against this backdrop, the OI of its March Futures contract declined 4.7%, indicating short-covering. Meanwhile, the call option OI on the 178.25 and 180 contracts fell 0.8% and 1.0%, respectively.  

⭐Granules arm gets clean chit by USFDA
₹288 6 (+2.2%)

Shares of Granules India surged more than 2% on Tuesday, while the OI of its March Futures contract fell 0.3%, indicating short-covering. This comes after the pharmaceutical company's arm, Granules Consumer Health, received zero observations in its audit by the USFDA. The USFDA inspected the company's packaging unit in Manassas from 15 to 20 March.  


Derivatives trading must be done only by traders who fully understand the risks associated with them and strictly apply risk mechanisms like stop-losses. The information is only for consumption by the client and such material should not be redistributed. We do not recommend any particular stock, securities and strategies for trading. The securities quoted are exemplary and are not recommendatory. The stock names mentioned in this article are purely for showing how to do analysis. Take your own decision before investing.

Never miss a trading opportunity with Margin Trading Facility

Enjoy 2X leverage on over 475+ stocks